RET and non-small cell lung carcinoma: These include TAS0953 (NCT04683250) for RET fusion positive cells [173], BOS172738 for RET fusion-positive NSCLC [159], RXDX-105 for CCDC6–RET, NCOA4–RET, and PRKAR1A–RET-containing cells [150], and TPX-0046 for advanced solid tumors with RET fusions or mutations [152,159].